These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6189849)

  • 21. An ELISA technique to detect IgG antibody to the early herpes simplex virus type 2 (HSV-2) antigen AG-4 in HSV-2 patients.
    Evans L; Arsenakis M; Sheppard M; May JT
    J Virol Methods; 1983 May; 6(5):245-54. PubMed ID: 6308025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoblotting and enzyme-linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2.
    Lehtinen M; Koivisto V; Lehtinen T; Paavonen J; Leinikki P
    Intervirology; 1985; 24(1):18-25. PubMed ID: 2995271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid solid-phase radioimmunoassay for detection of equine infectious anemia viral antigen and antibodies: parameters involved in standardization.
    Horenstein AL; Feinstein RE
    J Virol Methods; 1985 Oct; 12(1-2):1-11. PubMed ID: 3001113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.
    Källander CF; Torfason EG; Olding-Stenkvist E; Sundqvist VA; Diderholm H; Gronowitz JS
    J Med Virol; 1989 May; 28(1):30-7. PubMed ID: 2542443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.
    Schmidt NJ; Gallo D
    J Med Virol; 1984; 13(1):1-12. PubMed ID: 6319583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and evaluation of an ELISA using secreted recombinant glycoprotein B for determination of IgG antibody to herpes simplex virus.
    Revello MG; Gualandri R; Manservigi R; Gerna G
    J Virol Methods; 1991 Sep; 34(1):57-70. PubMed ID: 1659581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens.
    Kalimo KO; Marttila RJ; Granfors K; Viljanen MK
    Infect Immun; 1977 Mar; 15(3):883-9. PubMed ID: 192678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of antibody to viral proteins following primary infection with herpes simplex virus.
    Simmonds P; Smith IW; Peutherer JF
    J Med Virol; 1987 Oct; 23(2):191-205. PubMed ID: 2824685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid-phase and solid-phase radioimmunoassay with herpes simlex virus type 1 nucleocapsids.
    Bystrická M; Földes O; Sadlon J; Rajcáni J; Libíková H; Sabo A
    Acta Virol; 1985 Mar; 29(2):111-8. PubMed ID: 2860794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSV-1 gB and VZV gp-II crossreactive antibodies in human sera.
    Kühn JE; Klaffke K; Munk K; Braun RW
    Arch Virol; 1990; 112(3-4):203-13. PubMed ID: 2165766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-herpes simplex type 1 activity in IgG subclasses produced systemically and intrathecally in patients with herpes encephalitis.
    Johansson PJ; Blomberg J
    J Neurol; 1986 Oct; 233(5):289-96. PubMed ID: 3021917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of an ELISA technique with quantal micro-neutralization test for serotyping of HSV-1 or HSV-2-infected patients.
    Fortier B; Deville Chabrolle A; Huraux JM
    J Virol Methods; 1982 Sep; 5(1):11-20. PubMed ID: 6292248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of protein A-treated sera in unmasking herpes simplex virus type 1 (HSV-1) immunoglobulin A and identifying HSV-1 immunoglobulin G as the predominant neutralizing antibody.
    Ratner JJ; Sanford BA; Smith KO
    J Clin Microbiol; 1979 Oct; 10(4):415-8. PubMed ID: 231047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralizing activity of antibodies against the major herpes simplex virus type 1 glycoproteins.
    Eing BR; Kühn JE; Braun RW
    J Med Virol; 1989 Jan; 27(1):59-65. PubMed ID: 2466100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection.
    Sherlock CH; Ashley RL; Shurtleff ML; Mack KD; Corey L
    J Clin Microbiol; 1986 Dec; 24(6):1093-7. PubMed ID: 3023439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides.
    Bernstein DI; Bryson YJ; Lovett MA
    J Med Virol; 1985 Mar; 15(3):251-63. PubMed ID: 2580054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme-linked immunosorbent assay (ELISA) for detection of herpes simplex virus-specific IgM antibodies.
    Kimmel N; Friedman MG; Sarov I
    J Virol Methods; 1982 May; 4(4-5):219-27. PubMed ID: 6286702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific IgG and IgA antibodies to herpes simplex virus (HSV)-induced surface antigen in patients with HSV infections and in healthy adults.
    Hadar T; Sarov I
    J Med Virol; 1984; 14(3):201-7. PubMed ID: 6094720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the solid-phase radioimmunoassay for diagnosis of St. Louis encephalitis infection in humans.
    Wolff KL; Muth DJ; Hudson BW; Trent DW
    J Clin Microbiol; 1981 Aug; 14(2):135-40. PubMed ID: 6168650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.